[Synbiotech] Immune Checkpoint Proteins

[Synbiotech] Immune Checkpoint Proteins

​

 

​

​

​

​

Partial Products List

Cat #	Protein	Expression system	Size	Price ($)
EXH1002	Human PD-L1 with C-His	Expi293	1mg	$2,381.32
EXH1003	Human LIGHT with C-His	Expi293	1mg	$2,645.91
EXH1004	Human PD1 with C-hFc	Expi293	1mg	$2,381.32
EXH1005	Human PD1 with C-His	Expi293	1mg	$2,381.32
EXH1006	Human ICOS with C-His	Expi293	1mg	$2,778.21
EXH1007	Human CD40 with C-His	Expi293	1mg	$1,719.84
EXM1008	Mouse CD40 with C-His	Expi293	1mg	$2,116.73
EXH1009	Human CD40 Ligand with N-His-Flag	Expi293	1mg	$2,381.32
EXM1010	Mouse CD40 Ligand with N-hFc	Expi293	1mg	$2,249.03
EXH1011	Human CD40 Ligand with N-hFc	Expi293	1mg	$2,381.32
EXH1012	Human OX40/CD134 with C-hFc	Expi293	1mg	$2,116.73
EXH1013	Human OX40/CD134 with C-His-Avi	Expi293	1mg	$1,984.44
EXH1014	Human CD47 with C-His	Expi293	1mg	$2,513.62
EXH1015	Human CD47 with C-hFc	Expi293	1mg	$2,381.32
EXH1016	Human CD80 with C-hFc	Expi293	1mg	$2,116.73
EXH1017	Human CTLA-4 with C-His	Expi293	1mg	$992.22
EXH1018	Human TIM-3 with C-His	Expi293	1mg	$2,381.32
EXM1019	MouseTIM-3 with C-His	Expi293	1mg	$2,116.73
EXH1020	Human TIGIT with C-His	Expi293	1mg	$2,579.77
EXH1021	Human GITR with C-His	Expi293	1mg	$2,381.32
EXM1022	Mouse GITR with C-His	Expi293	1mg	$2,381.32
EXH1023	Human SIRP alpha with C-His	Expi293	1mg	$2,381.32
EXH1024	Human CD86 with C-His-Avi	Expi293	1mg	$1,984.44
EXH1025	Human 4-1BB with C-His	Expi293	1mg	$2,778.21
EXH1026	Human CD137L with N-hFc	Expi293	1mg	$2,910.51
EXH1027	Human VISTA with C-His	Expi293	1mg	$2,116.73
EXM1028	Mouse VISTA with C-His	Expi293	1mg	$2,116.73
EXH1029	Human BTLA with C-His-Avi	Expi293	1mg	$2,910.51
EXH1030	Human ICOSLG with C-His-Avi	Expi293	1mg	$1,455.25
EXH1031	Human CD155 with C-hFc	Expi293	1mg	$2,116.73
EXH1032	Human CD155 with C-His-Avi	Expi293	1mg	$2,116.73
EXH1033	Human PD-L2 with C-His-Avi	Expi293	1mg	$1,918.29
EXH1034	Human B7-H3 with C-His	Expi293	1mg	$2,116.73
EXH1035	Human CD70 with N-hFc	Expi293	1mg	$1,455.25

In recent years, clinical studies have found that tumor cells are highly expressed by immune checkpoint proteins to reduce the intensity of the body’s innate and adaptive immune response while promoting the “Immune Escape” of tumor cells. Therefore, therapeutic monoclonal antibodies that target immune checkpoint proteins have become the latest strategy for cancer treatment. Examples include anti-CTLA-4 antibody (Iplimumab), anti-PD-1 monoclonal antibody (Nivolumab, Pembrolizumab), and anti-PD-L1 monoclonal antibody (Avelumab, Atezolizumab, Durvalumab, etc.).

Synbio Technologies supplies most of the popular immune checkpoint proteins, including CTLA-4, PD-1, PD-L1, CD47, GITR, TIM-3/TIM1, etc.

​

​

​

휴바이오랩 (Hubiolab)

hubiolab@gmail.com

010-9468-7169

www.hubiolab.com